ESC Premium Access

Triple therapy: still an option?

Congress Presentation

About the speaker

Professor Kurt Huber

Wilhelminen Hospital, Vienna (Austria)
54 presentations

3 more presentations in this session

A historical perspective: why we opted triple therapy for so long and what made us change our mind.

Speaker: Professor D. Angiolillo (Jacksonville, US)


Dual versus triple antithrombotic therapy, does trial design make the difference?

Speaker: Professor R. Storey (Sheffield, GB)


Dual versus triple antithrombotic therapy - The fine art of personalised medicine.

Speaker: Professor R. De Caterina (Pisa, IT)


Access the full session

Dual versus Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Stenting

Speakers: Professor K. Huber, Professor D. Angiolillo, Professor R. Storey, Professor R. De Caterina

About the event


ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb